Skip to content
hcg-service-hero-1

Insights From Halloran

Nicole GalloApr 8, 2024 12:15:00 PM1 min read

Successful Planning for an Original NDA / BLA Submission

This comprehensive webinar offers an insightful exploration into the intricate landscape ...
Start Reading
Halloran Consulting GroupApr 4, 2024 12:17:00 PM4 min read

Critical Steps Towards a Collaborative Partnership and Governance Model

When crucial clinical trial activities are delegated by a sponsor to their vendor, the ...
Start Reading
Meaghan PowersMar 28, 2024 12:19:00 PM2 min read

The Vital Role of Collaboration and Leadership in Phase 2 Trials

In the intricate world of pharmaceutical development, the journey from a promising ...
Start Reading
Meaghan PowersMar 25, 2024 12:18:00 PM3 min read

Leveraging Outsourcing and Mixed Model Staffing Amid Layoffs

In the dynamic landscape of business, layoffs or losing momentum in a program with faulty ...
Start Reading
Gail WinslowMar 22, 2024 12:19:00 PM2 min read

Navigating the Path to FDA Approval: The Importance of a PDUFA Date

As a biopharmaceutical company advancing through the phases of clinical development, each ...
Start Reading
Halloran Consulting GroupMar 19, 2024 8:58:00 AM4 min read

Moving Towards Sustainability in Clinical Research – Call to Action  

The life sciences industry is becoming more focused on sustainability practices – a ...
Start Reading
Elizabeth BodiMar 13, 2024 12:13:00 PM4 min read

Elevating Your Clinical Trial Audits with AI and Centralized Monitoring 

This article is written by Elizabeth Bodi and Mike Lynch. Clinical trial audits serve as ...
Start Reading
Sheila GwizdakMar 7, 2024 12:14:00 PM7 min read

Quality Governance and Evolution of Quality Management Review 

Quality governance can be defined as an overarching framework that provides assurance of ...
Start Reading
Kanchana IyerMar 7, 2024 11:33:00 AM1 min read

Bringing In Vitro Diagnostics to Market with Real-World Evidence

In vitro diagnostic (IVD) devices are a unique type of medical device. Although they meet ...
Start Reading
Michael Fusakio, PhDMar 1, 2024 12:14:00 PM5 min read

Preparing Now for FDA START Program for Rare Disease Drug Developers 

On September 29, 2023, the U.S. Food and Drug Administration (FDA) took action to help ...
Start Reading